奇正消痛贴膏联合玻璃酸钠注射液治疗膝关节骨性关节炎的临床疗效

被引：11

作者：

邵银初

胡炜

李浩

杨红

双峰

机构：

[1] 解放军第九四医院骨科

来源：

医学综述 | 2018年 / 24卷 / 17期

关键词：

膝关节骨性关节炎; 奇正消痛贴膏; 玻璃酸钠注射液;

D O I：

暂无

中图分类号：

R684.3 [关节炎];

学科分类号：

100220 [骨科学];

摘要：

目的观察奇正消痛贴膏外用联合玻璃酸钠注射液膝关节内注射治疗膝关节骨性关节炎的临床疗效。方法选择2014年1月至2015年7月解放军第九四医院收治的96例膝关节骨性关节炎患者为研究对象,按照随机数字法分为对照组和观察组,各48例。对照组给予麝香壮骨膏联合玻璃酸钠注射液治疗,观察组给予奇正消痛贴膏联合玻璃酸钠注射液治疗。治疗前和治疗5周后,对两组进行膝关节炎纽约特种外科医院膝关节评分(HSS),评价疼痛程度和关节功能。结果观察组总有效率高于对照组[85.35%(41/48)比60.42%(29/48)](P<0.05)。治疗后,观察组疼痛、功能、活动度、肌力、屈膝畸形、稳定性、总分高于对照组[(21.56±4.74)分比(18.02±6.42)分,(18.50±5.51)分比(13.15±5.71)分,(12.54±3.31)分比(11.27±2.09)分,(8.25±0.67)分比(7.33±2.08)分,(8.55±0.91)分比(7.40±1.59)分,(9.54±0.85)分比(9.13±1.03)分,(77.52±5.83)分比(66.21±3.46)分](P<0.05)。观察组5例(10.42%),对照组有3例(6.25%)出现瘙痒、烧灼感,两组不良反应发生率比较差异无统计学意义(P>0.05)。结论奇正消痛贴膏或麝香壮骨膏联合玻璃酸钠注射液治疗膝关节骨性关节炎均有良好的疗效,奇正消痛贴膏的临床效果更优。

引用

页码：3497 / 3501

页数：5

共 15 条

[1]

Efficacy and safety of hyaluronic acid in the management of osteoarthritis: Evidence from real-life setting trials and surveys [J].

Maheu, Emmanuel ;

Rannou, Francois ;

Reginster, Jean-Yves .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2016, 45 (04) :S28-S33

[2]

Imaging for osteoarthritis [J].

Hayashi, D. ;

Roemer, F. W. ;

Guermazi, A. .

ANNALS OF PHYSICAL AND REHABILITATION MEDICINE, 2016, 59 (03) :161-169

[3]

Assessment of clinical practice guideline methodology for the treatment of knee osteoarthritis with intra-articular hyaluronic acid [J].

Altman, Roy D. ;

Schemitsch, Emil ;

Bedi, Asheesh .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 45 (02) :132-139

[4]

Cross-cultural adaptation, reliability and validity of the Turkish version of the Hospital for Special Surgery (HSS) Knee Score [J].

Narin, Selnur ;

Unver, Bayram ;

Bakirhan, Serkan ;

Bozan, Ozgur ;

Karatosun, Vasfi .

ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA, 2014, 48 (03) :241-248

[5]

OARSI guidelines for the non-surgical management of knee osteoarthritis [J].

McAlindon, T. E. ;

Bannuru, R. R. ;

Sullivan, M. C. ;

Arden, N. K. ;

Berenbaum, F. ;

Bierma-Zeinstra, S. M. ;

Hawker, G. A. ;

Henrotin, Y. ;

Hunter, D. J. ;

Kawaguchi, H. ;

Kwoh, K. ;

Lohmander, S. ;

Rannou, F. ;

Roos, E. M. ;

Underwood, M. .

OSTEOARTHRITIS AND CARTILAGE, 2014, 22 (03) :363-388

[6]

Risk factors for and prevalence of knee osteoarthritis in the rural areas of Shanxi Province, North China: a COPCORD study [J].

Zhang, Junfeng ;

Song, Linghua ;

Liu, Guifen ;

Zhang, Ailian ;

Dong, Haiyuan ;

Liu, Zhiyong ;

Li, Xiaofeng ;

Luo, Jing .

RHEUMATOLOGY INTERNATIONAL, 2013, 33 (11) :2783-2788

[7]

The American Academy of Orthopaedic Surgeons evidence-based guideline on: treatment of osteoarthritis of the knee; 2nd edition..[J].Jevsevar David S;Brown Gregory Alexander;Jones Dina L;Matzkin Elizabeth G;Manner Paul A;Mooar Pekka;Schousboe John T;Stovitz Steven;Sanders James O;Bozic Kevin J;Goldberg Michael J;Martin William Robert;Cummins Deborah S;Donnelly Patrick;Woznica Anne;Gross Leeaht.The Journal of bone and joint surgery. American volume.2013, 20

[8]

Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study [J].